With second quarter results in hand, Novadaq (NVDQ)
continues to look like a rare med-tech story with both very strong
growth and large addressable markets trading at something close to a
reasonable valuation. "Reasonable" is a subjective assessment, of
course, it will take many years of exceptional growth for Novadaq to
earn its valuation, but I believe the company's strong portfolio of
surgical imaging technologies can drive that growth.
Please read the full article at Seeking Alpha:
Novadaq On Track To Bring Excellent Growth To Light
No comments:
Post a Comment